Cambridge Enterprise, Sydney Children's Hospitals Network design viral vectors encoding factor I Nov. 30, 2017 No Comments
HanAll initiates phase II trial of HL-036 to treat signs and symptoms of dry eye Nov. 30, 2017 No Comments
Phase II results for nesvacumab and aflibercept combination therapy do not warrant progression Nov. 27, 2017 No Comments
First subject dosed in phase III study of Nevakar's ophthalmic solution for myopia in children Nov. 23, 2017 No Comments
RSS